Effect of High Protein Diet on Adiponectin & Inflammation Among Overweight

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research

See also
Status	Clinical Trial	Phase
Completed	`NCT01886482` - Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children	Phase 3
Suspended	`NCT01782027` - Mendelian Reverse Cholesterol Transport Study	N/A
Completed	`NCT00005188` - Quantitative Genetic Analysis of Lipid Research Clinic Family Data	N/A
Completed	`NCT01763528` - High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women	Phase 3

See also

Status

Clinical Trial

Phase

Completed

NCT01886482 - Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children

Phase 3

Suspended

NCT01782027 - Mendelian Reverse Cholesterol Transport Study

N/A

Completed

NCT00005188 - Quantitative Genetic Analysis of Lipid Research Clinic Family Data

N/A

Completed

NCT01763528 - High Protein Weight Loss Diet, High Sensitivity C-Reactive Protein and Cardiovascular Risks Among Obese Women

Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01886495
Study type	Interventional
Source	Isfahan University of Medical Sciences
Contact
Status	Completed
Phase	Phase 3
Start date	September 2011
Completion date	September 2012

Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms